Loading…
Reported covered position: Deputy Director of Health, HELP, Sen. Edward Kennedy; Health Policy Advisor, Sen. Barack Obama; Counselor for Science and Public Health, HHS
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Client: CRAIGSLIST, INC. · Firm: SIDLEY AUSTIN LLP
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Client: CRAIGSLIST, INC. · Firm: SIDLEY AUSTIN LLP
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
MEDELA LLC via SIDLEY AUSTIN LLP
2018 · second_quarter · 2A
Issues related to infant nutrition and health, maternal health, and breastfeeding support
Filing targets: Health & Human Services, Dept of (HHS)
MELINTA THERAPEUTICS via SIDLEY AUSTIN LLP
2018 · third_quarter · 3T
Source: Senate LDA
| VIFOR PHARMA LTD |
| 8 |
| 2016–2018 |
| GW PHARMA INC. | 7 | 2015–2016 |
| CLAIM YOUR HEALTH DATA COALITION | 5 | 2016–2017 |
| CRAIGSLIST, INC. | 4 | 2017–2018 |
| MEDICAL INFORMATION WORKING GROUP | 4 | 2015–2016 |
| THERMO FISHER SCIENTIFIC | 4 | 2016 |
| EUROIMMUN US, INC. | 3 | 2016 |
| Exact Sciences Corporation | 3 | 2015–2016 |
| MELINTA THERAPEUTICS | 3 | 2018 |
| NEVRO CORP. | 3 | 2018 |
| THE MEDICINES COMPANY | 3 | 2015–2016 |
| THE SSI GROUP | 3 | 2015–2016 |
| VERTOS MEDICAL | 3 | 2016 |
| HIKVISION, USA INC. | 2 | 2018 |
Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Client: CRAIGSLIST, INC. · Firm: SIDLEY AUSTIN LLP
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Client: CRAIGSLIST, INC. · Firm: SIDLEY AUSTIN LLP
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Client: CRAIGSLIST, INC. · Firm: SIDLEY AUSTIN LLP
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Client: CRAIGSLIST, INC. · Firm: SIDLEY AUSTIN LLP
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Client: CRAIGSLIST, INC. · Firm: SIDLEY AUSTIN LLP
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Client: CRAIGSLIST, INC. · Firm: SIDLEY AUSTIN LLP
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Client: CRAIGSLIST, INC. · Firm: SIDLEY AUSTIN LLP
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Client: CRAIGSLIST, INC. · Firm: SIDLEY AUSTIN LLP
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Privacy Notification Technical Clarification Act
Client: GARMIN INTERNATIONAL, INC. · Firm: SIDLEY AUSTIN LLP
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
Privacy Notification Technical Clarification Act
Client: GARMIN INTERNATIONAL, INC. · Firm: SIDLEY AUSTIN LLP
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
Privacy Notification Technical Clarification Act
Client: GARMIN INTERNATIONAL, INC. · Firm: SIDLEY AUSTIN LLP
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
Privacy Notification Technical Clarification Act
Client: GARMIN INTERNATIONAL, INC. · Firm: SIDLEY AUSTIN LLP
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
John S. McCain National Defense Authorization Act for Fiscal Year 2019
Client: HIKVISION USA, INC. · Firm: SIDLEY AUSTIN LLP
Prohibitions on certain video surveillance equipment in the National Defense Authorization Act (HR 5515) and other potential legislation.
John S. McCain National Defense Authorization Act for Fiscal Year 2019
Client: HIKVISION USA, INC. · Firm: SIDLEY AUSTIN LLP
Prohibitions on certain video surveillance equipment in the National Defense Authorization Act (HR 5515) and other potential legislation.
John S. McCain National Defense Authorization Act for Fiscal Year 2019
Client: HIKVISION USA, INC. · Firm: SIDLEY AUSTIN LLP
Prohibitions on certain video surveillance equipment in the National Defense Authorization Act (HR 5515) and other potential legislation.
John S. McCain National Defense Authorization Act for Fiscal Year 2019
Client: HIKVISION USA, INC. · Firm: SIDLEY AUSTIN LLP
Prohibitions on certain video surveillance equipment in the National Defense Authorization Act (HR 5515) and other potential legislation.
John S. McCain National Defense Authorization Act for Fiscal Year 2019
Client: HIKVISION USA, INC. · Firm: SIDLEY AUSTIN LLP
Prohibitions on certain video surveillance equipment in the National Defense Authorization Act (HR 5515) and other potential legislation.
John S. McCain National Defense Authorization Act for Fiscal Year 2019
Client: HIKVISION USA, INC. · Firm: SIDLEY AUSTIN LLP
Prohibitions on certain video surveillance equipment in the National Defense Authorization Act (HR 5515) and other potential legislation.
John S. McCain National Defense Authorization Act for Fiscal Year 2019
Client: HIKVISION USA, INC. · Firm: SIDLEY AUSTIN LLP
Prohibitions on certain video surveillance equipment in the National Defense Authorization Act (HR 5515) and other potential legislation.
John S. McCain National Defense Authorization Act for Fiscal Year 2019
Client: HIKVISION USA, INC. · Firm: SIDLEY AUSTIN LLP
Prohibitions on certain video surveillance equipment in the National Defense Authorization Act (HR 5515) and other potential legislation.
John S. McCain National Defense Authorization Act for Fiscal Year 2019
Client: HIKVISION USA, INC. · Firm: SIDLEY AUSTIN LLP
Prohibitions on certain video surveillance equipment in the National Defense Authorization Act (HR 5515) and other potential legislation.
John S. McCain National Defense Authorization Act for Fiscal Year 2019
Client: HIKVISION USA, INC. · Firm: SIDLEY AUSTIN LLP
Prohibitions on certain video surveillance equipment in the National Defense Authorization Act (HR 5515) and other potential legislation.
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Client: CRAIGSLIST, INC. · Firm: SIDLEY AUSTIN LLP
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Client: CRAIGSLIST, INC. · Firm: SIDLEY AUSTIN LLP
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Client: CRAIGSLIST, INC. · Firm: SIDLEY AUSTIN LLP
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Client: CRAIGSLIST, INC. · Firm: SIDLEY AUSTIN LLP
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Client: CRAIGSLIST, INC. · Firm: SIDLEY AUSTIN LLP
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Client: CRAIGSLIST, INC. · Firm: SIDLEY AUSTIN LLP
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Client: CRAIGSLIST, INC. · Firm: SIDLEY AUSTIN LLP
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Client: CRAIGSLIST, INC. · Firm: SIDLEY AUSTIN LLP
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Client: CRAIGSLIST, INC. · Firm: SIDLEY AUSTIN LLP
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Client: CRAIGSLIST, INC. · Firm: SIDLEY AUSTIN LLP
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Privacy Notification Technical Clarification Act
Client: GARMIN INTERNATIONAL, INC. · Firm: SIDLEY AUSTIN LLP
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
Privacy Notification Technical Clarification Act
Client: GARMIN INTERNATIONAL, INC. · Firm: SIDLEY AUSTIN LLP
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
Privacy Notification Technical Clarification Act
Client: GARMIN INTERNATIONAL, INC. · Firm: SIDLEY AUSTIN LLP
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
Privacy Notification Technical Clarification Act
Client: GARMIN INTERNATIONAL, INC. · Firm: SIDLEY AUSTIN LLP
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
Privacy Notification Technical Clarification Act
Client: GARMIN INTERNATIONAL, INC. · Firm: SIDLEY AUSTIN LLP
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
Privacy Notification Technical Clarification Act
Client: GARMIN INTERNATIONAL, INC. · Firm: SIDLEY AUSTIN LLP
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
Privacy Notification Technical Clarification Act
Client: GARMIN INTERNATIONAL, INC. · Firm: SIDLEY AUSTIN LLP
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
Privacy Notification Technical Clarification Act
Client: GARMIN INTERNATIONAL, INC. · Firm: SIDLEY AUSTIN LLP
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015
Client: VIFOR PHARMA LTD · Firm: SIDLEY AUSTIN LLP
Regulation of complex large-molecule drugs by the Food and Drug Administration, H.R.1576 (Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015)
Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015
Client: VIFOR PHARMA LTD · Firm: SIDLEY AUSTIN LLP
Regulation of complex large-molecule drugs by the Food and Drug Administration, H.R.1576 (Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015)
Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015
Client: VIFOR PHARMA LTD · Firm: SIDLEY AUSTIN LLP
Regulation of complex large-molecule drugs by the Food and Drug Administration, H.R.1576 (Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015)
Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015
Client: VIFOR PHARMA LTD · Firm: SIDLEY AUSTIN LLP
Regulation of complex large-molecule drugs by the Food and Drug Administration, H.R.1576 (Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015)
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015
Client: VIFOR PHARMA LTD · Firm: SIDLEY AUSTIN LLP
Regulation of complex large-molecule drugs by the Food and Drug Administration, H.R.1576 (Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015)
Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015
Client: VIFOR PHARMA LTD · Firm: SIDLEY AUSTIN LLP
Regulation of complex large-molecule drugs by the Food and Drug Administration, H.R.1576 (Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015)
FDA and DEA regulation of cannabidiol; monitor S. 1333 (Therapeutic Hemp Medical Access Act of 2015), HR 1635 (Charlotte's Web Medical Access Act of 2015), S. 683/S. 1538 (Compassionate Access, Research Expansion and Respect States Act) and activity related to medical marijuana research
FDA and DEA regulation of cannabidiol; monitor S. 1333 (Therapeutic Hemp Medical Access Act of 2015), HR 1635 (Charlotte's Web Medical Access Act of 2015), S. 683/S. 1538 (Compassionate Access, Research Expansion and Respect States Act) and activity related to medical marijuana research
FDA and DEA regulation of cannabidiol; monitor S. 1333 (Therapeutic Hemp Medical Access Act of 2015), HR 1635 (Charlotte's Web Medical Access Act of 2015), S. 683/S. 1538 (Compassionate Access, Research Expansion and Respect States Act) and activity related to medical marijuana research
Sensible Oversight for Technology which Advances Regulatory Efficiency Act
Client: GARMIN INTERNATIONAL, INC. · Firm: SIDLEY AUSTIN LLP
H.R. 6, 21st Century Cures Act, H.R. 2396, the SOFTWARE Act, the Senate FDA Innovations bill, S. 1101, the MEDTECH Act
Sensible Oversight for Technology which Advances Regulatory Efficiency Act
Client: GARMIN INTERNATIONAL, INC. · Firm: SIDLEY AUSTIN LLP
H.R. 6, 21st Century Cures Act, H.R. 2396, the SOFTWARE Act, the Senate FDA Innovations bill, S. 1101, the MEDTECH Act
Sensible Oversight for Technology which Advances Regulatory Efficiency Act
Client: GARMIN INTERNATIONAL, INC. · Firm: SIDLEY AUSTIN LLP
H.R. 6, 21st Century Cures Act, H.R. 2396, the SOFTWARE Act, the Senate FDA Innovations bill, S. 1101, the MEDTECH Act
Sensible Oversight for Technology which Advances Regulatory Efficiency Act
Client: GARMIN INTERNATIONAL, INC. · Firm: SIDLEY AUSTIN LLP
H.R. 6, 21st Century Cures Act, H.R. 2396, the SOFTWARE Act, the Senate FDA Innovations bill, S. 1101, the MEDTECH Act
Sensible Oversight for Technology which Advances Regulatory Efficiency Act
Client: GARMIN INTERNATIONAL, INC. · Firm: SIDLEY AUSTIN LLP
H.R. 6, 21st Century Cures Act, H.R. 2396, the SOFTWARE Act, the Senate FDA Innovations bill, S. 1101, the MEDTECH Act
Medicare reimbursement
Medicare reimbursement
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MELINTA THERAPEUTICS via SIDLEY AUSTIN LLP
2018 · second_quarter · Q2
Medicare reimbursement
Medicare reimbursement
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MELINTA THERAPEUTICS via SIDLEY AUSTIN LLP
2018 · second_quarter · RR
Medicare reimbursement
Medicare reimbursement
PURDUE PHARMA L.P. via SIDLEY AUSTIN LLP
2018 · third_quarter · Q3
Patient access to abuse deterrent pain relief drugs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTREXON CORPORATION via SIDLEY AUSTIN LLP
2018 · third_quarter · Q3
Educate and seek assistance from congressional offices and Administration officials on issues related to genetically engineered foods.
Educate congressional offices on issues related to genetically engineered foods
Educate and seek assistance from congressional offices and Administration officials on issues related to genetically engineered foods.
Education and policy advocacy related to the creation and development of fuels
Educate and seek assistance from congressional offices and Administration officials on issues related to genetically engineered foods.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE, White House Office
CORD BLOOD ASSOCIATION via SIDLEY AUSTIN LLP
2018 · third_quarter · Q3
Legislative and Federal agency activities related to the Stem Cell Therapeutic and Research Reauthorization Act of 2015
Legislative and Federal agency activities related to the Stem Cell Therapeutic and Research Reauthorization Act of 2015
Legislative and Federal agency activities related to the Stem Cell Therapeutic and Research Reauthorization Act of 2015
Filing targets: Food & Drug Administration (FDA), Health Resources & Services Administration (HRSA)
NEVRO CORP. via SIDLEY AUSTIN LLP
2018 · third_quarter · 3T
Legislation addressing non-opioid pain management
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTREXON CORPORATION via SIDLEY AUSTIN LLP
2018 · second_quarter · Q2
Educate and seek assistance from congressional offices and Administration officials on issues related to genetically engineered foods.
Educate and seek assistance from congressional offices and Administration officials on issues related to genetically engineered foods.
Education and policy advocacy related to the creation and development of fuels
HIKVISION USA, INC. via SIDLEY AUSTIN LLP
2018 · second_quarter · Q2
Prohibitions on certain video surveillance equipment in the National Defense Authorization Act (HR 5515) and other potential legislation.
Prohibitions on certain video surveillance equipment in the National Defense Authorization Act (HR 5515) and other potential legislation.
Prohibitions on certain video surveillance equipment in the National Defense Authorization Act (HR 5515) and other potential legislation.
GARMIN INTERNATIONAL, INC. via SIDLEY AUSTIN LLP
2018 · second_quarter · Q2
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CRAIGSLIST, INC. via SIDLEY AUSTIN LLP
2018 · second_quarter · Q2
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
CORD BLOOD ASSOCIATION via SIDLEY AUSTIN LLP
2018 · second_quarter · Q2
Legislative and Federal agency activities related to the Stem Cell Therapeutic and Research Reauthorization Act of 2015
Legislative and Federal agency activities related to the Stem Cell Therapeutic and Research Reauthorization Act of 2015
Legislative and Federal agency activities related to the Stem Cell Therapeutic and Research Reauthorization Act of 2015
Filing targets: Food & Drug Administration (FDA), Health Resources & Services Administration (HRSA)
VIFOR PHARMA LTD via SIDLEY AUSTIN LLP
2018 · second_quarter · Q2
Regulation of complex large-molecule drugs by the Food and Drug Administration
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA L.P. via SIDLEY AUSTIN LLP
2018 · second_quarter · Q2
Patient access to abuse deterrent pain relief drugs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEVRO CORP. via SIDLEY AUSTIN LLP
2018 · second_quarter · Q2
Legislation addressing non-opioid pain management
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDELA LLC via SIDLEY AUSTIN LLP
2018 · second_quarter · Q2
Issues related to infant nutrition and health, maternal health, and breastfeeding support
Filing targets: Health & Human Services, Dept of (HHS)
HIKVISION USA, INC. via SIDLEY AUSTIN LLP
2018 · second_quarter · RR
Prohibitions on certain video surveillance equipment in the National Defense Authorization Act (HR 5515) and other potential legislation.
Prohibitions on certain video surveillance equipment in the National Defense Authorization Act (HR 5515) and other potential legislation.
Prohibitions on certain video surveillance equipment in the National Defense Authorization Act (HR 5515) and other potential legislation.
NEVRO CORP. via SIDLEY AUSTIN LLP
2018 · second_quarter · RR
Legislation addressing non-opioid pain management
INTREXON CORPORATION via SIDLEY AUSTIN LLP
2018 · first_quarter · 1A
Educate and seek assistance from congressional offices and Administration officials on issues related to genetically engineered foods.
Educate and seek assistance from congressional offices and Administration officials on issues related to genetically engineered foods.
Educate congressional offices on issues related to genetically engineered foods
VIFOR PHARMA LTD via SIDLEY AUSTIN LLP
2018 · first_quarter · Q1
Regulation of complex large-molecule drugs by the Food and Drug Administration
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SHIRE PHARMACEUTICALS LLC via SIDLEY AUSTIN LLP
2018 · first_quarter · Q1
Medicare
Filing targets: SENATE
PURDUE PHARMA L.P. via SIDLEY AUSTIN LLP
2018 · first_quarter · Q1
Patient access to abuse deterrent pain relief drugs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDELA LLC via SIDLEY AUSTIN LLP
2018 · first_quarter · Q1
Issues related to infant nutrition and health, maternal health, and breastfeeding support
Filing targets: Health & Human Services, Dept of (HHS)
INTREXON CORPORATION via SIDLEY AUSTIN LLP
2018 · first_quarter · Q1
Advocating before the U.S. Congress and Administration to increase awareness of its self-limiting mosquitoes; to accelerate Food and Drug Administration approval of the mosquito; and to identify and secure Federal sources of funding for the self-limiting mosquito programs in the U.S. and overseas; advocating before the U.S. Congress and Administration to increase awareness relating to genetically engineered products
Advocating before the U.S. Congress and Administration to increase awareness of its self-limiting mosquitoes; to accelerate Food and Drug Administration approval of the mosquito; and to identify and secure Federal sources of funding for the self-limiting mosquito programs in the U.S. and overseas
GARMIN INTERNATIONAL, INC. via SIDLEY AUSTIN LLP
2018 · first_quarter · Q1
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CRAIGSLIST, INC. via SIDLEY AUSTIN LLP
2018 · first_quarter · Q1
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
CORD BLOOD ASSOCIATION via SIDLEY AUSTIN LLP
2018 · first_quarter · Q1
Legislative and Federal agency activities related to the Stem Cell Therapeutic and Research Reauthorization Act of 2015
Legislative and Federal agency activities related to the Stem Cell Therapeutic and Research Reauthorization Act of 2015
Legislative and Federal agency activities related to the Stem Cell Therapeutic and Research Reauthorization Act of 2015
Filing targets: Food & Drug Administration (FDA), Health Resources & Services Administration (HRSA)
SHIRE PHARMACEUTICALS LLC via SIDLEY AUSTIN LLP
2017 · fourth_quarter · 4A
Medicare
Filing targets: SENATE
VIFOR PHARMA LTD via SIDLEY AUSTIN LLP
2017 · fourth_quarter · Q4
Regulation of complex large-molecule drugs by the Food and Drug Administration, H.R.1576 (Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SHIRE PHARMACEUTICALS LLC via SIDLEY AUSTIN LLP
2017 · fourth_quarter · Q4
Medicare
Filing targets: SENATE
PURDUE PHARMA L.P. via SIDLEY AUSTIN LLP
2017 · fourth_quarter · Q4
Patient access to abuse deterrent pain relief drugs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDELA LLC via SIDLEY AUSTIN LLP
2017 · fourth_quarter · Q4
Issues related to infant nutrition and health, maternal health, and breastfeeding support
Filing targets: Health & Human Services, Dept of (HHS)
INTREXON CORPORATION via SIDLEY AUSTIN LLP
2017 · fourth_quarter · Q4
Advocating before the U.S. Congress and Administration to increase awareness of its self-limiting mosquitoes; to accelerate Food and Drug Administration approval of the mosquito; and to identify and secure Federal sources of funding for the self-limiting mosquito programs in the U.S. and overseas
Advocating before the U.S. Congress and Administration to increase awareness of its self-limiting mosquitoes; to accelerate Food and Drug Administration approval of the mosquito; and to identify and secure Federal sources of funding for the self-limiting mosquito programs in the U.S. and overseas; advocating before the U.S. Congress and Administration to increase awareness relating to genetically engineered products
GARMIN INTERNATIONAL, INC. via SIDLEY AUSTIN LLP
2017 · fourth_quarter · Q4
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CRAIGSLIST, INC. via SIDLEY AUSTIN LLP
2017 · fourth_quarter · Q4
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
CORD BLOOD ASSOCIATION via SIDLEY AUSTIN LLP
2017 · fourth_quarter · Q4
Legislative and Federal agency activities related to H.R.2820 (Health Equity Act of 2013) and the Stem Cell Therapeutic and Research Reauthorization Act of 2015
Legislative and Federal agency activities related to H.R.2820 (Health Equity Act of 2013) and the Stem Cell Therapeutic and Research Reauthorization Act of 2015
Legislative and Federal agency activities related to H.R.2820 (Health Equity Act of 2013) and the Stem Cell Therapeutic and Research Reauthorization Act of 2015
Filing targets: Food & Drug Administration (FDA), Health Resources & Services Administration (HRSA)
CRAIGSLIST, INC. via SIDLEY AUSTIN LLP
2017 · fourth_quarter · RR
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
VIFOR PHARMA LTD via SIDLEY AUSTIN LLP
2017 · third_quarter · Q3
Regulation of complex large-molecule drugs by the Food and Drug Administration, H.R.1576 (Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SHIRE PHARMACEUTICALS LLC via SIDLEY AUSTIN LLP
2017 · third_quarter · Q3
Medicare
Filing targets: SENATE
PURDUE PHARMA L.P. via SIDLEY AUSTIN LLP
2017 · third_quarter · Q3
Patient access to abuse deterrent pain relief drugs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDELA LLC via SIDLEY AUSTIN LLP
2017 · third_quarter · Q3
Issues related to infant nutrition and health, maternal health, and breastfeeding support
Filing targets: Health & Human Services, Dept of (HHS)
INTREXON CORPORATION via SIDLEY AUSTIN LLP
2017 · third_quarter · Q3
Advocating before the U.S. Congress and Administration to increase awareness of genetically engineered products
Advocating before the U.S. Congress and Administration to increase awareness of its self-limiting mosquitoes; to accelerate Food and Drug Administration approval of the mosquito; and to identify and secure Federal sources of funding for the self-limiting mosquito programs in the U.S. and overseas; advocating before the U.S. Congress and Administration to increase awareness relating to genetically engineered products
Advocating before the U.S. Congress and Administration to increase awareness of its self-limiting mosquitoes; to accelerate Food and Drug Administration approval of the mosquito; and to identify and secure Federal sources of funding for the self-limiting mosquito programs in the U.S. and overseas
GARMIN INTERNATIONAL, INC. via SIDLEY AUSTIN LLP
2017 · third_quarter · Q3
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CORD BLOOD ASSOCIATION via SIDLEY AUSTIN LLP
2017 · third_quarter · Q3
Legislative and Federal agency activities related to H.R.2820 (Health Equity Act of 2013) and the Stem Cell Therapeutic and Research Reauthorization Act of 2015
Legislative and Federal agency activities related to H.R.2820 (Health Equity Act of 2013) and the Stem Cell Therapeutic and Research Reauthorization Act of 2015
Legislative and Federal agency activities related to H.R.2820 (Health Equity Act of 2013) and the Stem Cell Therapeutic and Research Reauthorization Act of 2015
Filing targets: Food & Drug Administration (FDA), Health Resources & Services Administration (HRSA)
SHIRE PHARMACEUTICALS LLC via SIDLEY AUSTIN LLP
2017 · second_quarter · Q2
Medicare
Filing targets: SENATE
VIFOR PHARMA LTD via SIDLEY AUSTIN LLP
2017 · second_quarter · Q2
Regulation of complex large-molecule drugs by the Food and Drug Administration, H.R.1576 (Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA L.P. via SIDLEY AUSTIN LLP
2017 · second_quarter · Q2
Patient access to abuse deterrent pain relief drugs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDELA LLC via SIDLEY AUSTIN LLP
2017 · second_quarter · Q2
Issues related to infant nutrition and health, maternal health, and breastfeeding support
Filing targets: Health & Human Services, Dept of (HHS)
INTREXON CORPORATION via SIDLEY AUSTIN LLP
2017 · second_quarter · Q2
Advocating before the U.S. Congress and Administration to increase awareness of its self-limiting mosquitoes; to accelerate Food and Drug Administration approval of the mosquito; and to identify and secure Federal sources of funding for the self-limiting mosquito programs in the U.S. and overseas
Advocating before the U.S. Congress and Administration to increase awareness of its self-limiting mosquitoes; to accelerate Food and Drug Administration approval of the mosquito; and to identify and secure Federal sources of funding for the self-limiting mosquito programs in the U.S. and overseas; advocating before the U.S. Congress and Administration to increase awareness relating to genetically engineered products
GARMIN INTERNATIONAL, INC. via SIDLEY AUSTIN LLP
2017 · second_quarter · Q2
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CORD BLOOD ASSOCIATION via SIDLEY AUSTIN LLP
2017 · second_quarter · Q2
Legislative and Federal agency activities related to H.R.2820 (Health Equity Act of 2013) and the Stem Cell Therapeutic and Research Reauthorization Act of 2015
Legislative and Federal agency activities related to H.R.2820 (Health Equity Act of 2013) and the Stem Cell Therapeutic and Research Reauthorization Act of 2015
Legislative and Federal agency activities related to H.R.2820 (Health Equity Act of 2013) and the Stem Cell Therapeutic and Research Reauthorization Act of 2015
Filing targets: Food & Drug Administration (FDA), Health Resources & Services Administration (HRSA)
VIFOR PHARMA LTD via SIDLEY AUSTIN LLP
2017 · first_quarter · Q1
Regulation of complex large-molecule drugs by the Food and Drug Administration, H.R.1576 (Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SHIRE PHARMACEUTICALS LLC via SIDLEY AUSTIN LLP
2017 · first_quarter · Q1
Medicare
Filing targets: SENATE
PURDUE PHARMA L.P. via SIDLEY AUSTIN LLP
2017 · first_quarter · Q1
Patient access to abuse deterrent pain relief drugs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDELA LLC via SIDLEY AUSTIN LLP
2017 · first_quarter · Q1
Issues related to infant nutrition and health, maternal health, and breastfeeding support
Filing targets: Health & Human Services, Dept of (HHS)
INTREXON CORPORATION via SIDLEY AUSTIN LLP
2017 · first_quarter · Q1
Advocating before the U.S. Congress and Administration to increase awareness of its self-limiting mosquitoes; to accelerate Food and Drug Administration approval of the mosquito; and to identify and secure Federal sources of funding for the self-limiting mosquito programs in the U.S. and overseas
Advocating before the U.S. Congress and Administration to increase awareness of its self-limiting mosquitoes; to accelerate Food and Drug Administration approval of the mosquito; and to identify and secure Federal sources of funding for the self-limiting mosquito programs in the U.S. and overseas
GARMIN INTERNATIONAL, INC. via SIDLEY AUSTIN LLP
2017 · first_quarter · Q1
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
H.R.6, 21st Century Cures Act; H.R.2396, the SOFTWARE Act, the Senate FDA Innovations bill; S.1101, the MEDTECH Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CORD BLOOD ASSOCIATION via SIDLEY AUSTIN LLP
2017 · first_quarter · Q1
Legislative and Federal agency activities related to H.R.2820 (Health Equity Act of 2013) and the Stem Cell Therapeutic and Research Reauthorization Act of 2015
Legislative and Federal agency activities related to H.R.2820 (Health Equity Act of 2013) and the Stem Cell Therapeutic and Research Reauthorization Act of 2015
Legislative and Federal agency activities related to H.R.2820 (Health Equity Act of 2013) and the Stem Cell Therapeutic and Research Reauthorization Act of 2015
Filing targets: Food & Drug Administration (FDA), Health Resources & Services Administration (HRSA)
CLAIM YOUR HEALTH DATA COALITION via SIDLEY AUSTIN LLP
2017 · first_quarter · Q1
Issues related to health IT and medical records
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDELA LLC via SIDLEY AUSTIN LLP
2017 · first_quarter · RR
Issues related to infant nutrition and health, maternal health, and breastfeeding support
VIFOR PHARMA LTD via SIDLEY AUSTIN LLP
2016 · fourth_quarter · Q4
Regulation of complex large-molecule drugs by the Food and Drug Administration, H.R.1576 (Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERTOS MEDICAL via SIDLEY AUSTIN LLP
2016 · fourth_quarter · Q4
Educate Congressional and agency staff on Vertos innovative technology to treat lumbar spinal stenosis (LSS) and explain the regulatory challenges it has faced regarding Medicare coverage.
Educate Congressional and agency staff on Vertos innovative technology to treat lumbar spinal stenosis (LSS) and explain the regulatory challenges it has faced regarding Medicare coverage.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SHIRE PHARMACEUTICALS LLC via SIDLEY AUSTIN LLP
2016 · fourth_quarter · Q4
Medicare
Filing targets: SENATE
PURDUE PHARMA L.P. via SIDLEY AUSTIN LLP
2016 · fourth_quarter · Q4
Patient access to abuse deterrent pain relief drugs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTREXON CORPORATION via SIDLEY AUSTIN LLP
2016 · fourth_quarter · Q4
Advocating before the U.S. Congress and Administration to increase awareness of its self-limiting mosquitoes; to accelerate Food and Drug Administration ("FDA") approval of the mosquito; and to identify and secure Federal sources of funding for the self-limiting mosquito programs in the U.S. and overseas
Advocating before the U.S. Congress and Administration to increase awareness of its self-limiting mosquitoes; to accelerate Food and Drug Administration ("FDA") approval of the mosquito; and to identify and secure Federal sources of funding for the self-limiting mosquito programs in the U.S. and overseas
GW PHARMA INC. via SIDLEY AUSTIN LLP
2016 · fourth_quarter · Q4
FDA and DEA regulation of cannabidiol; monitor S. 1333 (Therapeutic Hemp Medical Access Act of 2015), HR 1635 (Charlotte's Web Medical Access Act of 2015), S. 683/S. 1538 (Compassionate Access, Research Expansion and Respect States Act) and activity related to medical marijuana research
GARMIN INTERNATIONAL, INC. via SIDLEY AUSTIN LLP
2016 · fourth_quarter · Q4
H.R. 6, 21st Century Cures Act, H.R. 2396, the SOFTWARE Act, the Senate FDA Innovations bill, S. 1101, the MEDTECH Act
H.R. 6, 21st Century Cures Act, H.R. 2396, the SOFTWARE Act, the Senate FDA Innovations bill, S. 1101, the MEDTECH Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CORD BLOOD ASSOCIATION via SIDLEY AUSTIN LLP
2016 · fourth_quarter · Q4
Legislative and Federal agency activities related to H.R.2820 (Health Equity Act of 2013) and the Stem Cell Therapeutic and Research Reauthorization Act of 2015
Legislative and Federal agency activities related to H.R.2820 (Health Equity Act of 2013) and the Stem Cell Therapeutic and Research Reauthorization Act of 2015
Legislative and Federal agency activities related to H.R.2820 (Health Equity Act of 2013) and the Stem Cell Therapeutic and Research Reauthorization Act of 2015
Filing targets: Food & Drug Administration (FDA), Health Resources & Services Administration (HRSA)
CLAIM YOUR HEALTH DATA COALITION via SIDLEY AUSTIN LLP
2016 · fourth_quarter · Q4
Issues related to health IT and medical records
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERTOS MEDICAL via SIDLEY AUSTIN LLP
2016 · third_quarter · Q3
Educate Congressional and agency staff on Vertos innovative technology to treat lumbar spinal stenosis (LSS) and explain the regulatory challenges it has faced regarding Medicare coverage.
Educate Congressional and agency staff on Vertos innovative technology to treat lumbar spinal stenosis (LSS) and explain the regulatory challenges it has faced regarding Medicare coverage.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VERTOS MEDICAL via SIDLEY AUSTIN LLP
2016 · third_quarter · RR
Educate congressional and agency staff on Vertos innovative technology to treat lumbar spinal stenosis (LSS) and explain the regulatory challenges it has faced regarding Medicare coverage.
Educate congressional and agency staff on Vertos innovative technology to treat lumbar spinal stenosis (LSS) and explain the regulatory challenges it has faced regarding Medicare coverage.
VIFOR PHARMA LTD via SIDLEY AUSTIN LLP
2016 · third_quarter · Q3
Regulation of complex large-molecule drugs by the Food and Drug Administration, H.R.1576 (Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SHIRE PHARMACEUTICALS LLC via SIDLEY AUSTIN LLP
2016 · third_quarter · Q3
Medicare
Filing targets: SENATE
THERMO FISHER SCIENTIFIC via SIDLEY AUSTIN LLP
2016 · third_quarter · 3T
Providing strategic advice and assistance regarding outreach to Federal agencies and Congress on diagnostic products for the Zika virus.
Providing strategic advice and assistance regarding outreach to Federal agencies and Congress on diagnostic products for the Zika virus.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA L.P. via SIDLEY AUSTIN LLP
2016 · third_quarter · Q3
Patient access to abuse deterrent pain relief drugs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICAL INFORMATION WORKING GROUP via SIDLEY AUSTIN LLP
2016 · third_quarter · Q3
Potential legislation under the 21st Century Cures Initiative of the House Energy & Commerce Committee affecting the dissemination of information by pharmaceutical and medical device manufacturers. Potential FDA regulations and policies affecting the dissemination of information by pharmaceutical and medical device manufacturers.
Potential legislation under the 21st Century Cures Initiative of the House Energy & Commerce Committee affecting the dissemination of information by pharmaceutical and medical device manufacturers. Potential FDA regulations and policies affecting the dissemination of information by pharmaceutical and medical device manufacturers.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES
INTREXON CORPORATION via SIDLEY AUSTIN LLP
2016 · third_quarter · Q3
Advocating before the U.S. Congress and Administration to increase awareness of its self-limiting mosquitoes; to accelerate Food and Drug Administration ("FDA") approval of the mosquito; and to identify and secure Federal sources of funding for the self-limiting mosquito programs in the U.S. and overseas
Advocating before the U.S. Congress and Administration to increase awareness of its self-limiting mosquitoes; to accelerate Food and Drug Administration ("FDA") approval of the mosquito; and to identify and secure Federal sources of funding for the self-limiting mosquito programs in the U.S. and overseas
GW PHARMA INC. via SIDLEY AUSTIN LLP
2016 · third_quarter · Q3
FDA and DEA regulation of cannabidiol; monitor S. 1333 (Therapeutic Hemp Medical Access Act of 2015), HR 1635 (Charlotte's Web Medical Access Act of 2015), S. 683/S. 1538 (Compassionate Access, Research Expansion and Respect States Act) and activity related to medical marijuana research
GARMIN INTERNATIONAL, INC. via SIDLEY AUSTIN LLP
2016 · third_quarter · Q3
H.R. 6, 21st Century Cures Act, H.R. 2396, the SOFTWARE Act, the Senate FDA Innovations bill, S. 1101, the MEDTECH Act
H.R. 6, 21st Century Cures Act, H.R. 2396, the SOFTWARE Act, the Senate FDA Innovations bill, S. 1101, the MEDTECH Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EUROIMMUN US, INC. via SIDLEY AUSTIN LLP
2016 · third_quarter · 3T
Providing strategic advice and assistance regarding outreach to Federal agencies and Congress on diagnostic products for the Zika virus
Providing strategic advice and assistance regarding outreach to Federal agencies and Congress on diagnostic products for the Zika virus
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CORD BLOOD ASSOCIATION via SIDLEY AUSTIN LLP
2016 · third_quarter · Q3
Legislative and Federal agency activities related to H.R.2820 (Health Equity Act of 2013) and the Stem Cell Therapeutic and Research Reauthorization Act of 2015
Legislative and Federal agency activities related to H.R.2820 (Health Equity Act of 2013) and the Stem Cell Therapeutic and Research Reauthorization Act of 2015
Legislative and Federal agency activities related to H.R.2820 (Health Equity Act of 2013) and the Stem Cell Therapeutic and Research Reauthorization Act of 2015
Filing targets: Food & Drug Administration (FDA), Health Resources & Services Administration (HRSA)
CLAIM YOUR HEALTH DATA COALITION via SIDLEY AUSTIN LLP
2016 · third_quarter · Q3
Issues related to health IT and medical records
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GARMIN INTERNATIONAL, INC. via SIDLEY AUSTIN LLP
2016 · third_quarter · RR
H.R. 6, 21st Century Cures Act, H.R. 2396, the SOFTWARE Act, the Senate FDA Innovations bill, S. 1101, the MEDTECH Act
H.R. 6, 21st Century Cures Act, H.R. 2396, the SOFTWARE Act, the Senate FDA Innovations bill, S. 1101, the MEDTECH Act
SHIRE PHARMACEUTICALS LLC via SIDLEY AUSTIN LLP
2016 · second_quarter · Q2
Medicare
Filing targets: SENATE
SHIRE PHARMACEUTICALS LLC via SIDLEY AUSTIN LLP
2016 · second_quarter · RR
Medicare
PURDUE PHARMA L.P. via SIDLEY AUSTIN LLP
2016 · second_quarter · 2A
Patient access to abuse deterrent pain relief drugs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CLAIM YOUR HEALTH DATA COALITION via SIDLEY AUSTIN LLP
2016 · second_quarter · Q2
Issues related to health IT and medical records
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THERMO FISHER SCIENTIFIC via SIDLEY AUSTIN LLP
2016 · second_quarter · Q2
Providing strategic advice and assistance regarding outreach to Federal agencies and Congress on diagnostic products for the Zika virus.
Providing strategic advice and assistance regarding outreach to Federal agencies and Congress on diagnostic products for the Zika virus.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA L.P. via SIDLEY AUSTIN LLP
2016 · second_quarter · Q2
Patient access to abuse deterrent pain relief drugs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE MEDICINES COMPANY via SIDLEY AUSTIN LLP
2016 · second_quarter · 2T
Antibiotics development as it relates to various legislative proposals and agency rulemaking activities
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICAL INFORMATION WORKING GROUP via SIDLEY AUSTIN LLP
2016 · second_quarter · Q2
Potential legislation under the 21st Century Cures Initiative of the House Energy & Commerce Committee affecting the dissemination of information by pharmaceutical and medical device manufacturers. Potential FDA regulations and policies affecting the dissemination of information by pharmaceutical and medical device manufacturers.
Potential legislation under the 21st Century Cures Initiative of the House Energy & Commerce Committee affecting the dissemination of information by pharmaceutical and medical device manufacturers. Potential FDA regulations and policies affecting the dissemination of information by pharmaceutical and medical device manufacturers.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES
INTREXON CORPORATION via SIDLEY AUSTIN LLP
2016 · second_quarter · Q2
Advocating before the U.S. Congress and Administration to increase awareness of its self-limiting mosquitoes; to accelerate Food and Drug Administration ("FDA") approval of the mosquito; and to identify and secure Federal sources of funding for the self-limiting mosquito programs in the U.S. and overseas
Advocating before the U.S. Congress and Administration to increase awareness of its self-limiting mosquitoes; to accelerate Food and Drug Administration ("FDA") approval of the mosquito; and to identify and secure Federal sources of funding for the self-limiting mosquito programs in the U.S. and overseas
GW PHARMA INC. via SIDLEY AUSTIN LLP
2016 · second_quarter · Q2
FDA and DEA regulation of cannabidiol; monitor S. 1333 (Therapeutic Hemp Medical Access Act of 2015), HR 1635 (Charlotte's Web Medical Access Act of 2015), S. 683/S. 1538 (Compassionate Access, Research Expansion and Respect States Act) and activity related to medical marijuana research
EUROIMMUN US, INC. via SIDLEY AUSTIN LLP
2016 · second_quarter · Q2
Providing strategic advice and assistance regarding outreach to Federal agencies and Congress on diagnostic products for the Zika virus
Providing strategic advice and assistance regarding outreach to Federal agencies and Congress on diagnostic products for the Zika virus
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CORD BLOOD ASSOCIATION via SIDLEY AUSTIN LLP
2016 · second_quarter · Q2
Legislative and Federal agency activities related to H.R.2820 (Health Equity Act of 2013) and the Stem Cell Therapeutic and Research Reauthorization Act of 2015
Legislative and Federal agency activities related to H.R.2820 (Health Equity Act of 2013) and the Stem Cell Therapeutic and Research Reauthorization Act of 2015
Legislative and Federal agency activities related to H.R.2820 (Health Equity Act of 2013) and the Stem Cell Therapeutic and Research Reauthorization Act of 2015
Filing targets: Food & Drug Administration (FDA), Health Resources & Services Administration (HRSA)
CLAIM YOUR HEALTH DATA COALITION via SIDLEY AUSTIN LLP
2016 · second_quarter · RR
Issues related to health IT and medical records
EUROIMMUN US, INC. via SIDLEY AUSTIN LLP
2016 · second_quarter · RR
Providing strategic advice and assistance regarding outreach to Federal agencies and Congress on diagnostic products for the Zika virus.
Providing strategic advice and assistance regarding outreach to Federal agencies and Congress on diagnostic products for the Zika virus.
THERMO FISHER SCIENTIFIC via SIDLEY AUSTIN LLP
2016 · second_quarter · RA
Providing strategic advice and assistance regarding outreach to Federal agencies and Congress on diagnostic products for the Zika virus.
Providing strategic advice and assistance regarding outreach to Federal agencies and Congress on diagnostic products for the Zika virus.
THERMO FISHER SCIENTIFIC via SIDLEY AUSTIN LLP
2016 · second_quarter · RR
Providing strategic advice and assistance regarding outreach to federal agencies and Congress on diagnostic products for the Zika virus.
Providing strategic advice and assistance regarding outreach to federal agencies and Congress on diagnostic products for the Zika virus.
Educate congressional offices on issues related to genetically engineered foods
Educate and seek assistance from congressional offices and Administration officials on issues related to genetically engineered foods.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE, White House Office
Prohibitions on certain video surveillance equipment in the National Defense Authorization Act (HR 5515) and other potential legislation.
Prohibitions on certain video surveillance equipment in the National Defense Authorization Act (HR 5515) and other potential legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Prohibitions on certain video surveillance equipment in the National Defense Authorization Act (HR 5515) and other potential legislation.
Prohibitions on certain video surveillance equipment in the National Defense Authorization Act (HR 5515) and other potential legislation.
Educate and seek assistance from congressional offices and Administration officials on issues related to genetically engineered foods.
Education and policy advocacy related to the creation and development of fuels
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE, White House Office
Advocating before the U.S. Congress and Administration to increase awareness of its self-limiting mosquitoes; to accelerate Food and Drug Administration approval of the mosquito; and to identify and secure Federal sources of funding for the self-limiting mosquito programs in the U.S. and overseas
Advocating before the U.S. Congress and Administration to increase awareness of its self-limiting mosquitoes; to accelerate Food and Drug Administration approval of the mosquito; and to identify and secure Federal sources of funding for the self-limiting mosquito programs in the U.S. and overseas
Education and policy advocacy related to the creation and development of fuels.
Advocating before the U.S. Congress and Administration to increase awareness of genetically engineered products
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, White House Office
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Advocating before the U.S. Congress and Administration to increase awareness of its self-limiting mosquitoes; to accelerate Food and Drug Administration approval of the mosquito; and to identify and secure Federal sources of funding for the self-limiting mosquito programs in the U.S. and overseas
Advocating before the U.S. Congress and Administration to increase awareness of genetically engineered products
Education and policy advocacy related to the creation and development of fuels.
Advocating before the U.S. Congress and Administration to increase awareness of its self-limiting mosquitoes; to accelerate Food and Drug Administration approval of the mosquito; and to identify and secure Federal sources of funding for the self-limiting mosquito programs in the U.S. and overseas
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, White House Office
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Education and policy advocacy related to the creation and development of fuels.
Advocating before the U.S. Congress and Administration to increase awareness of its self-limiting mosquitoes; to accelerate Food and Drug Administration approval of the mosquito; and to identify and secure Federal sources of funding for the self-limiting mosquito programs in the U.S. and overseas
Advocating before the U.S. Congress and Administration to increase awareness of its self-limiting mosquitoes; to accelerate Food and Drug Administration approval of the mosquito; and to identify and secure Federal sources of funding for the self-limiting mosquito programs in the U.S. and overseas
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, White House Office
Education and policy advocacy related to the creation and development of fuels.
Advocating before the U.S. Congress and Administration to increase awareness of its self-limiting mosquitoes; to accelerate Food and Drug Administration approval of the mosquito; and to identify and secure Federal sources of funding for the self-limiting mosquito programs in the U.S. and overseas
Advocating before the U.S. Congress and Administration to increase awareness of its self-limiting mosquitoes; to accelerate Food and Drug Administration approval of the mosquito; and to identify and secure Federal sources of funding for the self-limiting mosquito programs in the U.S. and overseas
Advocating before the U.S. Congress and Administration to increase awareness of genetically engineered products
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, White House Office
Advocating before the U.S. Congress and Administration to increase awareness of its self-limiting mosquitoes; to accelerate Food and Drug Administration approval of the mosquito; and to identify and secure Federal sources of funding for the self-limiting mosquito programs in the U.S. and overseas
Advocating before the U.S. Congress and Administration to increase awareness of its self-limiting mosquitoes; to accelerate Food and Drug Administration approval of the mosquito; and to identify and secure Federal sources of funding for the self-limiting mosquito programs in the U.S. and overseas
Education and policy advocacy related to the creation and development of fuels.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, White House Office
Advocating before the U.S. Congress and Administration to increase awareness of its self-limiting mosquitoes; to accelerate Food and Drug Administration ("FDA") approval of the mosquito; and to identify and secure Federal sources of funding for the self-limiting mosquito programs in the U.S. and overseas
Advocating before the U.S. Congress and Administration to increase awareness of its self-limiting mosquitoes; to accelerate Food and Drug Administration ("FDA") approval of the mosquito; and to identify and secure Federal sources of funding for the self-limiting mosquito programs in the U.S. and overseas
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, White House Office
Advocating before the U.S. Congress and Administration to increase awareness of its self-limiting mosquitoes; to accelerate Food and Drug Administration ("FDA") approval of the mosquito; and to identify and secure Federal sources of funding for the self-limiting mosquito programs in the U.S. and overseas
Advocating before the U.S. Congress and Administration to increase awareness of its self-limiting mosquitoes; to accelerate Food and Drug Administration ("FDA") approval of the mosquito; and to identify and secure Federal sources of funding for the self-limiting mosquito programs in the U.S. and overseas
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, White House Office
Advocating before the U.S. Congress and Administration to increase awareness of its self-limiting mosquitoes; to accelerate Food and Drug Administration ("FDA") approval of the mosquito; and to identify and secure Federal sources of funding for the self-limiting mosquito programs in the U.S. and overseas
Advocating before the U.S. Congress and Administration to increase awareness of its self-limiting mosquitoes; to accelerate Food and Drug Administration ("FDA") approval of the mosquito; and to identify and secure Federal sources of funding for the self-limiting mosquito programs in the U.S. and overseas
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, White House Office